The emerging role of IL-23 in asthma and its clinical implications

Ashley Y Wu; R Stokes Peebles

doi:10.1080/1744666X.2023.2125380

The emerging role of IL-23 in asthma and its clinical implications

Expert Rev Clin Immunol. 2023 Jan;19(1):1-5. doi: 10.1080/1744666X.2023.2125380. Epub 2022 Sep 20.

Authors

Ashley Y Wu¹, R Stokes Peebles^{1

2

3

4}

Affiliations

¹ Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
² Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
³ Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
⁴ Tennessee Valley Healthcare System, United States Department of Veterans Affairs, Nashville, TN, USA.

No abstract available

Keywords: Airway inflammation; IL-23/Th17 axis; allergic disease; asthma; eosinophilic inflammation; group 2 innate lymphoid cells (ILC2); interleukin-17 (IL-17); interleukin-23 (IL-23); neutrophilic inflammation; type 2 inflammation.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Asthma*
Cytokines
Eosinophils
Humans
Immunity, Innate
Inflammation
Interleukin-23
Interleukin-33
Lymphocytes

Substances

Interleukin-23
Interleukin-33
Cytokines

Publication types

MeSH terms

Substances

Grants and funding